THURSDAY, AUGUST 22nd 2019
Jyrki Heino, Biocity Turku
Jukka Kola, Rector, University of Turku
Presentation of the Elias Tillandz prize for the best publication in BioCity Turku 2018
SESSION I – Early life, education of immune system (chair: Riitta Lahesmaa)
Petter Brodin, Karolinska Institutet, Stockholm, Sweden: Immune system development in early childhood.
Roser Vento-Tormo, Sanger Institute, UK: Reconstructing the maternal-fetal interference during early pregnancy.
POSTER SESSION A and coffee/tea with exhibition
Kathy McCoy, University of Calgary, Canada: Microbiome, Metabolites and Immune Responses.
Lunch and exhibition
SESSION II – Host metabolism and inflammation, metabolic disorders (Chair: Pirjo Nuutila)
Francesc Villarroya, University of Barcelona, Spain: Cross-talk of immune cells and brown adipocytes in the control of adaptive energy metabolism.
Gökhan S. Hotamışlıgil, Harvard University TH Chan School of Public Health, Boston, USA: Foundations of immunometabolism and implications for metabolic health and disease.
Ulf Smith, University of Gothenburg, Sweden: Senescence impairs cell differentiation and promotes inflammation in the adipose tissue.
End of first symposium day
Symposium dinner in Turku Castle
FRIDAY, AUGUST 23rd 2019
SESSION III – Neuro-immunology, microglia and neurodegenerative diseases (Chair: Juha Rinne and Laura Airas)
David Pitt, Yale School of Medicine, New Haven, USA: Astrocytes as mediators of inflammation in multiple sclerosis.
Anna Orr, Weill Cornell Medicine, New York, USA: Glial Cells and Neuroimmune Signaling in Cognitive Deficits.
POSTER SESSION B and coffee/tea with exhibition
Bengt Winblad, Karolinska Institutet, Stockholm, Sweden: Immunological treatment in Alzheimer’s disease.
Lunch and exhibition
SESSION IV – Onco-immunology to cure cancer (chair: Sirpa Jalkanen)
Arlene Sharpe, Harvard Medical School, Boston, USA: The biology behind PD-1 checkpoint blockade.
Angelica Loskog, Uppsala University, Sweden: CD40L/41BBL immunotherapy in pancreatic cancer – phase I/II interim report.
Tyler Curiel, UTHSCSA, Medicine, San Antonio, USA: Age effects on cancer immunotherapy.
Alexander Eggermont, Gustave Roussy CCC, France: The Immunotherapy Revolution: from melanoma to (almost) all tumors.
Jyrki Heino, University of Turku, Closing remarks